Red light therapy - also called photobiomodulation (PBM) - is one of the most studied non-invasive wellness technologies of the last two decades. But how much of the science is real, and how much is marketing? We reviewed the published clinical literature so you don't have to.
How It Works - The Science of Photobiomodulation
When specific wavelengths of light (typically 630-680nm red and 800-850nm near-infrared) penetrate the skin, they are absorbed by cytochrome c oxidase in cell mitochondria. This triggers a cascade of cellular responses:
- Increased ATP production - more cellular energy for repair and regeneration
- Reduced oxidative stress - lower levels of reactive oxygen species
- Enhanced blood flow - improved microcirculation to treated areas
- Collagen synthesis - stimulation of fibroblast activity
- Anti-inflammatory signalling - modulation of inflammatory cytokines
Lumovex devices use 660nm red light and 850nm near-infrared light - wavelengths selected specifically because they align with the most robust clinical evidence.
The Clinical Evidence
1. Skin Rejuvenation and Anti-Aging
Wunsch and Matuschka (2014) - Photomedicine and Laser Surgery
A randomised controlled trial of 136 volunteers found that subjects treated with 611-650nm and 570-850nm polychromatic light showed significantly improved skin complexion, skin feeling, and collagen density (measured by ultrasonography) compared to controls. Improvements were observed at 30 sessions and maintained at follow-up.
Barolet and colleagues (2009) - Journal of Investigative Dermatology
A split-face study using 660nm LED treatment showed a 47.7% increase in collagen density by ultrasound measurement. Participants also reported visible improvements in skin texture and fine lines.
Russell and colleagues (2005) - Journal of Cosmetic and Laser Therapy
Participants treated with 633nm and 830nm LED reported improvements in wrinkles, skin roughness, and overall complexion. 91% reported improved skin tone.
Park and colleagues (2025) - Medicine (Baltimore)
This randomised, double-blind, sham-controlled trial used 630nm + 850nm wavelengths - a near-exact match to Lumovex specifications. The treatment group showed an 86.2% improvement rate in crow's feet wrinkles compared to 16.7% in the sham control group.
Lumovex wavelength match: All four studies used wavelengths within the 630-660nm red and 830-850nm NIR range - directly aligned with the Spectrum Pro Mask's 660nm + 850nm output.
2. Acne Support
Sadick (2008) - Journal of Cosmetic and Laser Therapy
A study of combination red (633nm) and blue light therapy found a 76% mean improvement in inflammatory lesion count over 12 weeks.
Lee and colleagues (2007) - Photomedicine and Laser Surgery
Patients treated with 633nm red LED showed significant reduction in acne lesions compared to untreated controls, with improvements visible from week 4.
Alba and colleagues (2017) - Journal of the American Academy of Dermatology
This systematic review confirmed that red and blue light combination therapy showed consistent improvements in mild to moderate inflammatory acne across multiple trials.
Lumovex wavelength match: The studies used 620-660nm wavelengths. Lumovex's 660nm sits at the top of this proven therapeutic range.
3. Hair Growth
Lanzafame and colleagues (2014) - Lasers in Surgery and Medicine
A double-blind, sham device-controlled trial found that subjects using 655nm red light showed a statistically significant increase in hair count compared to sham controls over 16 weeks.
Kim and colleagues (2013) - Annals of Dermatology
A randomised, double-blind trial of 40 patients found a 39% increase in hair density in the red light group versus a 3% increase in the sham group at 24 weeks.
Jimenez and colleagues (2014) - American Journal of Clinical Dermatology
This multicenter randomised controlled trial of over 100 subjects demonstrated statistically significant hair count increases in the active treatment group versus sham, confirming earlier findings.
Lumovex wavelength match: Studies used 650-655nm - within 10nm of Lumovex's 660nm output.
4. Wound Healing and Recovery
Whelan and colleagues (2001) - NASA/Marshall Space Flight Center Study
This landmark NASA study found that 670nm LED light increased cell growth by 155-171% in fibroblasts and promoted wound healing in laboratory conditions. It established the scientific basis for LED-based photobiomodulation.
Chaves and colleagues (2014) - Photomedicine and Laser Surgery (Review)
This systematic review examined multiple wound healing studies and concluded that PBM using red and near-infrared wavelengths consistently promoted enhanced healing outcomes, including increased collagen deposition and reduced inflammation.
Avci and colleagues (2013) - Seminars in Cutaneous Medicine and Surgery (Review)
A comprehensive review of PBM mechanisms confirmed that wavelengths in the 600-700nm and 780-950nm ranges stimulate collagen synthesis, angiogenesis, and anti-inflammatory responses relevant to wound recovery.
Lumovex wavelength match: NASA used 670nm; the reviews encompassed 600-700nm plus 780-950nm. Lumovex's 660nm + 850nm falls squarely within both ranges.
5. Pain and Comfort
Bjordal and colleagues (2003) - Australian Journal of Physiotherapy
A systematic review and meta-analysis of 565 patients across multiple RCTs found that low-level laser therapy produced significant pain reduction in musculoskeletal disorders compared to placebo, with effects sustained across multiple treatment sessions.
Chow and colleagues (2009) - The Lancet (Oncology)
This meta-analysis of 16 randomised controlled trials found that low-level laser therapy significantly reduced pain intensity and duration, with effects persisting up to 22 weeks after treatment completion.
Tumilty and colleagues (2010) - Photomedicine and Laser Surgery
A systematic review of LLLT for tendinopathy found positive outcomes in the majority of included studies, particularly those using appropriate dosage parameters in the 780-860nm range.
Lumovex wavelength match: The pain studies used 780-950nm near-infrared wavelengths. Lumovex's 850nm is positioned in the centre of this therapeutic window. The Therapy Belt delivers this wavelength directly to the lower back and core - the areas most commonly treated in musculoskeletal pain studies.
6. Muscle Recovery and Athletic Performance
Leal-Junior and colleagues (2015) - Lasers in Medical Science
A comprehensive review of PBM in exercise found that pre-exercise application of red and near-infrared light significantly enhanced time to exhaustion, increased number of repetitions, and reduced markers of muscle damage (creatine kinase levels).
Ferraresi and colleagues (2012) - Photonics and Lasers in Medicine
This review found that PBM applied before or after exercise improved muscle performance and accelerated recovery across multiple studies, with wavelengths in the 630-660nm and 808-850nm ranges showing the strongest evidence.
Baroni and colleagues (2010) - Journal of Strength and Conditioning Research
A study using 810nm near-infrared light found that pre-exercise PBM significantly reduced muscle damage markers and maintained muscle force output compared to placebo.
Lumovex wavelength match: The 630-660nm plus 808-850nm range maps precisely to Lumovex's dual-wavelength output. Baroni specifically used 810nm - within 40nm of Lumovex's 850nm. The Pro Panel 540 is the most practical choice for pre and post-exercise application, covering large muscle groups in a single session.
7. Scar Appearance
Kurtti and colleagues (2021) - Photodermatology, Photoimmunology and Photomedicine
This randomised controlled trial found that red light therapy significantly improved surgical scar appearance and reduced scar thickness compared to control, with patients self-reporting improved satisfaction with healing outcomes.
Kim and colleagues (2022) - Lasers in Surgery and Medicine
A clinical study demonstrated that PBM using red wavelengths improved hypertrophic scar appearance, with measurable reductions in scar elevation and redness over the treatment period.
Lumovex wavelength match: Both studies used wavelengths in the 630-670nm range, consistent with Lumovex's 660nm output. For targeted scar treatment, the Sculpt Wand allows precise application directly to individual scars.
Why These Wavelengths Matter
Not all red light therapy devices are created equal. Many consumer devices use wavelengths outside the clinically studied ranges, or deliver insufficient irradiance to reach target tissues.
Lumovex specifically uses:
| Wavelength | Type | Penetration | Primary Evidence |
|---|---|---|---|
| 660nm | Visible red | 2-3mm (skin, surface tissue) | Skin rejuvenation, acne, hair growth, wound healing, scars |
| 850nm | Near-infrared | 5-10mm (deep tissue, muscle, joints) | Pain relief, muscle recovery, deep tissue repair, inflammation |
This dual-wavelength approach is supported by the strongest body of evidence in photobiomodulation research.
Transparency and Honesty
We believe in transparency. Here is what you should know:
- Red light therapy is not a medical treatment. It is a wellness tool that may support your body's natural processes.
- Results vary. Individual responses depend on skin type, condition severity, consistency of use, and other factors.
- These studies used clinical-grade protocols. Home devices like Lumovex deliver the same wavelengths at appropriate irradiance levels for consumer use.
- We cite real research. Every study referenced above is published in a peer-reviewed journal. We encourage you to verify them independently.
Ready to Try Clinically Studied Wavelengths?
Lumovex devices deliver 660nm + 850nm light - the same wavelength combination used across decades of clinical research. Explore the full range at lumovex.co.uk.
All studies referenced are published in peer-reviewed journals. Lumovex does not claim to treat, cure, or prevent any medical condition. Always consult a healthcare professional for medical advice.
Leave a comment
This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.